Risk factors of urinary tract infection after transurethral resection of prostate
SONG Jing1 ZHANG Ling-ling1 CHEN Lei1 WANG Yang2▲
1. Department of Urology, Hongqi Hospital Affiliated to Mudanjiang Medical University, Heilongjiang Province, Mudanjiang 157000, China;
2. Operating Room, Hongqi Hospital Affiliated to Mudanjiang Medical University, Heilongjiang Province, Mudanjiang 157000, China
Abstract:Objective To investigate the risk factors of urinary tract infection after transurethral resection of prostate.Methods A total of 200 cases of transurethral resection of prostate admitted to our hospital from January 2018 to February 2019 were selected as the study objects. According to the methods of postoperative urinary tract infection or not, they were divided into the observation group (100 cases) and the control group (100 cases). The observation group was accompanied by urinary tract infection, while the control group was free of urinary tract infection. The risk factors of urinary tract infection after transurethral prostatectomy was analyzed. Results There were statistically significant differences between the two groups of patients in age ≥70 years, operation time >1 h, indwelling catheter time >5 d, and preoperative preventive use of antibiotics without prevention (P<0.05). Taken age ≥70 years, operation time >1 h, indwelling catheter time >5 d, and preoperative not preventive use of antibiotics as independent variables, postoperative urinary tract infection as the dependent variable, Logistic regression analysis was conducted. According to the results,age ≥70 years, operation time >1 h, indwelling catheter time >5 d, and preoperative preventive use of antibiotics for the urethra prostate electricity cut method in patients were risk factors for urinary tract infection (P<0.05). Conclusion The risk factors for urinary tract infection after transurethral prostatectomy include age ≥70 years, operation time >1 h,indwelling catheter time >5 d, and preoperative not preventive use of antibiotics, and early reventive measures should be taken.
Chughtai B,Clemens JQ,Thomas D,et al.Real World Performance of Sacral Neuromodulation and OnabotulinumtoxinA for Overactive Bladder:Focus on Safety and Cost[J].J Urol,2020,203(1):179-184.